High levels of SARS-CoV-2-specific T cells with restricted functionality in severe courses of COVID-19.
Schub D, Klemis V, Schneitler S, Mihm J, Lepper PM, Wilkens H, Bals R, Eichler H, Gärtner BC, Becker SL, Sester U, Sester M, Schmidt T.
Schub D, et al. Among authors: sester m, sester u.
JCI Insight. 2020 Oct 15;5(20):e142167. doi: 10.1172/jci.insight.142167.
JCI Insight. 2020.
PMID: 32937615
Free PMC article.